Ohio § 2307.84

§ 2307.84.

As used in sections 2307.84 to 2307.90 and 2307.901 of the Revised Code : (A) “AMA guides to the evaluation of permanent impairment” means the American medical

association's guides to the evaluation of permanent impairment (fifth edition 2000)

as may be modified by the American medical association. (B) “ Board-certified internist ” means a medical doctor who is currently certified by the American board of internal

medicine. (C) “ Board-certified occupational medicine specialist ” means a medical doctor who is currently certified by the American board of preventive

medicine in the specialty of occupational medicine. (D) “ Board-certified oncologist ” means a medical doctor who is currently certified by the American board of internal

medicine in the subspecialty of medical oncology. (E) “ Board-certified pathologist ” means a medical doctor who is currently certified by the American board of pathology. (F) “ Board-certified pulmonary specialist ” means a medical doctor who is currently certified by the American board of internal

medicine in the subspecialty of pulmonary medicine. (G) “ Certified B-reader ” means an individual qualified as a “final” or “B-reader” as defined in 42 C.F.R. section 37.51(b) , as amended. (H) “ Civil action ” means all suits or claims of a civil nature in a state or federal court, whether

cognizable as cases at law or in equity or admiralty. “Civil action” does not include any of the following: (1) A civil action relating to any workers' compensation law; (2) A civil action alleging any claim or demand made against a trust established pursuant

to 11 U.S.C. section 524(g) ; (3) A civil action alleging any claim or demand made against a trust established pursuant

to a plan of reorganization confirmed under Chapter 11 of the United States Bankruptcy Code, 11 U.S.C. Chapter 11. (I) “ Competent medical authority ” means a medical doctor who is providing a diagnosis for purposes of constituting

prima-facie evidence of an exposed person's physical impairment that meets the requirements

specified in section 2307.85 or 2307.86 of the Revised Code , whichever is applicable, and who meets the following requirements: (1) The medical doctor is a board-certified internist, pulmonary specialist, oncologist,

pathologist, or occupational medicine specialist. (2) The medical doctor is actually treating or has treated the exposed person and has

or had a doctor-patient relationship with the person. (3) As the basis for the diagnosis, the medical doctor has not relied, in whole or in

part, on any of the following: (a) The reports or opinions of any doctor, clinic, laboratory, or testing company that

performed an examination, test, or screening of the claimant's medical condition in

violation of any law, regulation, licensing requirement, or medical code of practice

of the state in which that examination, test, or screening was conducted; (b) The reports or opinions of any doctor, clinic, laboratory, or testing company that

performed an examination, test, or screening of the claimant's medical condition that

was conducted without clearly establishing a doctor-patient relationship with the

claimant or medical personnel involved in the examination, test, or screening process; (c) The reports or opinions of any doctor, clinic, laboratory, or testing company that

performed an examination, test, or screening of the claimant's medical condition that

required the claimant to agree to retain the legal services of the law firm sponsoring

the examination, test, or screening. (4) The medical doctor spends not more than twenty-five per cent of the medical doctor's

professional practice time in providing consulting or expert services in connection

with actual or potential tort actions, and the medical doctor's medical group, professional

corporation, clinic, or other affiliated group earns not more than twenty per cent

of its revenues from providing those services. (J) “ Exposed person ” means either of the following, whichever is applicable: (1) A person whose exposure to silica is the basis for a silicosis claim under section 2307.85 of the Revised Code ; (2) A person whose exposure to mixed dust is the basis for a mixed dust disease claim

under section 2307.86 of the Revised Code . (K) “ ILO scale ” means the system for the classification of chest x-rays set forth in the international

labour office's guidelines for the use of ILO international classification of radiographs

of pneumoconioses (2000), as amended. (L) “ Lung cancer ” means a malignant tumor in which the primary site of origin of the cancer is inside

the lungs. (M) “ Mixed dust ” means a mixture of dusts composed of silica and one or more other fibrogenic dusts

capable of inducing pulmonary fibrosis if inhaled in sufficient quantity. (N) “ Mixed dust disease claim ” means any claim for damages, losses, indemnification, contribution, or other relief

arising out of, based on, or in any way related to inhalation of, exposure to, or

contact with mixed dust. “ Mixed dust disease claim ” includes a claim made by or on behalf of any person who has been exposed to mixed

dust, or any representative, spouse, parent, child, or other relative of that person,

for injury, including mental or emotional injury, death, or loss to person, risk of

disease or other injury, costs of medical monitoring or surveillance, or any other

effects on the person's health that are caused by the person's exposure to mixed dust. (O) “ Mixed dust pneumoconiosis ” means the interstitial lung disease caused by the pulmonary response to inhaled

mixed dusts. (P) “ Nonmalignant condition ” means a condition, other than a diagnosed cancer, that is caused or may be caused

by either of the following, whichever is applicable: (1) Silica, as provided in section 2307.85 of the Revised Code ; (2) Mixed dust, as provided in section 2307.86 of the Revised Code . (Q) “ Pathological evidence of mixed dust pneumoconiosis ” means a statement by a board-certified pathologist that more than one representative

section of lung tissue uninvolved with any other disease process demonstrates a pattern

of peribronchiolar and parenchymal stellate (star-shaped) nodular scarring and that

there is no other more likely explanation for the presence of the fibrosis. (R) “ Pathological evidence of silicosis ” means a statement by a board-certified pathologist that more than one representative

section of lung tissue uninvolved with any other disease process demonstrates a pattern

of round silica nodules and birefringent crystals or other demonstration of crystal

structures consistent with silica (well-organized concentric whorls of collagen surrounded

by inflammatory cells) in the lung parenchyma and that there is no other more likely

explanation for the presence of the fibrosis. (S) “ Physical impairment ” means any of the following, whichever is applicable: (1) A nonmalignant condition that meets the minimum requirements of division (B) of section 2307.85 of the Revised Code or lung cancer of an exposed person who is a smoker that meets the minimum requirements

of division (C) of section 2307.85 of the Revised Code ; (2) A nonmalignant condition that meets the minimum requirements of division (B) of section 2307.86 of the Revised Code or lung cancer of an exposed person who is a smoker that meets the minimum requirements

of division (C) of section 2307.86 of the Revised Code . (T) “ Premises owner ” means a person who owns, in whole or in part, leases, rents, maintains, or controls

privately owned lands, ways, or waters, or any buildings and structures on those lands,

ways, or waters, and all privately owned and state-owned lands, ways, or waters leased

to a private person, firm, or organization, including any buildings and structures

on those lands, ways, or waters. (U) “ Radiological evidence of mixed dust pneumoconiosis ” means a chest x-ray showing bilateral rounded or irregular opacities in the upper

lung fields graded by a certified B-reader as at least 1/1 on the ILO scale. (V) “ Radiological evidence of silicosis ” means a chest x-ray showing bilateral small rounded opacities (p, q, or r) in the

upper lung fields graded by a certified B-reader as at least 1/1 on the ILO scale. (W) “ Regular basis ” means on a frequent or recurring basis. (X) “ Silica ” means a respirable crystalline form of silicon dioxide, including, but not limited

to, alpha quartz, cristobalite, and trydmite. (Y) “ Silicosis claim ” means any claim for damages, losses, indemnification, contribution, or other relief

arising out of, based on, or in any way related to inhalation of, exposure to, or

contact with silica. “ Silicosis claim ” includes a claim made by or on behalf of any person who has been exposed to silica,

or any representative, spouse, parent, child, or other relative of that person, for

injury, including mental or emotional injury, death, or loss to person, risk of disease

or other injury, costs of medical monitoring or surveillance, or any other effects

on the person's health that are caused by the person's exposure to silica. (Z) “ Silicosis ” means an interstitial lung disease caused by the pulmonary response to inhaled silica. (AA) “ Smoker ” means a person who has smoked the equivalent of one-pack year, 1 as specified in the written report of a competent medical authority pursuant to section 2307.85 or 2307.86 and section 2307.87 of the Revised Code , during the last fifteen years. (BB) “ Substantial contributing factor ” means both of the following: (1) Exposure to silica or mixed dust is the predominate cause of the physical impairment

alleged in the silicosis claim or mixed dust disease claim, whichever is applicable. (2) A competent medical authority has determined with a reasonable degree of medical

certainty that without the silica or mixed dust exposures the physical impairment

of the exposed person would not have occurred. (CC) “ Substantial occupational exposure to silica ” means employment for a cumulative period of at least five years in an industry and

an occupation in which, for a substantial portion of a normal work year for that occupation,

the exposed person did any of the following: (1) Handled silica; (2) Fabricated silica-containing products so that the person was exposed to silica in

the fabrication process; (3) Altered, repaired, or otherwise worked with a silica-containing product in a manner

that exposed the person on a regular basis to silica; (4) Worked in close proximity to other workers engaged in any of the activities described

in division (CC)(1), (2), or (3) of this section in a manner that exposed the person

on a regular basis to silica. (DD) “ Substantial occupational exposure to mixed dust ” means employment for a cumulative period of at least five years in an industry and

an occupation in which, for a substantial portion of a normal work year for that occupation,

the exposed person did any of the following: (1) Handled mixed dust; (2) Fabricated mixed dust-containing products so that the person was exposed to mixed

dust in the fabrication process; (3) Altered, repaired, or otherwise worked with a mixed dust-containing product in a

manner that exposed the person on a regular basis to mixed dust; (4) Worked in close proximity to other workers engaged in any of the activities described

in division (DD)(1), (2), or (3) of this section in a manner that exposed the person

on a regular basis to mixed dust. (EE) “ Tort action ” means a civil action for damages for injury, death, or loss to person. “ Tort action ” includes a product liability claim that is subject to sections 2307.71 to 2307.80 of the Revised Code . “Tort action” does not include a civil action for damages for a breach of contract

or another agreement between persons. (FF) “ Veterans' benefit program ” means any program for benefits in connection with military service administered

by the veterans' administration under title 38 of the United States Code. (GG) “ Workers' compensation law ” means Chapters 4121., 4123., 4127., and 4131. of the Revised Code. 1

 So in original;  2004 H 342.